Literature DB >> 33546226

The Fertility Indicator Equation Using Serum Progesterone and Urinary Pregnanediol-3-Glucuronide for Assessment of Ovulatory to Luteal Phase Transition.

Stephen J Usala1, María Elena Alliende2, A Alexandre Trindade3.   

Abstract

Background and
Objectives: The Fertility Indicator Equation (FIE) has been shown to signal the fertile phase during the ovulatory menstrual cycle. It was hypothesized that this formulation, a product of two sequential normalized changes with a sign indicating direction of change, could be used to identify the transition from ovulatory to luteal phase with daily serum progesterone (P) and urinary pregnanediol-3-glucuronide (PDG) levels. Materials and
Methods: Day-specific serum P levels from two different laboratories and day-specific urinary PDG levels from an additional two different laboratories were submitted for FIE analysis. These day-specific levels included mean or median, 5th, 10th, 90th and 95th percentile data. They were indexed to the day of ovulation, day 0, by ultrasonography, serum or urinary luteinizing hormone (LH).
Results: All data sets showed a clear "cluster"-a periovulatory sequence of positive FIE values with a maximum. All clusters of +FIE signaled the transition from the ovulatory to luteal phase and were at least four days in length. The start day for the serum P and urinary PDG FIE clusters ranged from -3 to -1 and -3 to +2, respectively. The end day for serum P and PDG clusters went from +2 to +7 and +4 to +8, respectively. Outside these periovulatory FIE-P and FIE-PDG clusters, there were no consecutive positive FIE values. In addition, the maximum FIE-P and FIE-PDG values throughout the entire cycles were found in the clusters. Conclusions: FIE analysis with either daily serum P or urinary PDG levels provided a distinctive signature to recognize the periovulatory interval. The Fertility Indicator Equation served to robustly signal the transition from the ovulatory phase to the luteal phase. This may have applications in natural family planning especially with the recent emergence of home PDG tests.

Entities:  

Keywords:  PDG; fertility awareness methods; natural family planning; pregnanediol-3-glucuronide; progesterone

Mesh:

Substances:

Year:  2021        PMID: 33546226      PMCID: PMC7913371          DOI: 10.3390/medicina57020134

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  29 in total

1.  Estimated maximum failure rates of cycle monitors using daily conception probabilities in the menstrual cycle.

Authors:  G Freundl; E Godehardt; P A Kern; P Frank-Herrmann; H J Koubenec; Ch Gnoth
Journal:  Hum Reprod       Date:  2003-12       Impact factor: 6.918

2.  Personal fertility monitors for contraception.

Authors:  Thomas P Bouchard; Stephen J Genuis
Journal:  CMAJ       Date:  2010-11-15       Impact factor: 8.262

3.  Efficacy of the Marquette Method of natural family planning.

Authors:  Richard J Fehring; Mary Schneider; Mary Lee Barron
Journal:  MCN Am J Matern Child Nurs       Date:  2008 Nov-Dec       Impact factor: 1.412

4.  Concordance of Fingerstick and Venipuncture Sampling for Fertility Hormones.

Authors:  Erin E Burke; Safedin Beqaj; Nataki C Douglas; Robert Luo
Journal:  Obstet Gynecol       Date:  2019-02       Impact factor: 7.661

5.  Single luteal phase serum progesterone assay as an indicator of ovulation.

Authors:  R Israel; D R Mishell; S C Stone; I H Thorneycroft; D L Moyer
Journal:  Am J Obstet Gynecol       Date:  1972-04-15       Impact factor: 8.661

Review 6.  Fertility awareness-based methods of family planning.

Authors:  Rebecca G Simmons; Victoria Jennings
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2019-12-20       Impact factor: 5.237

7.  Use of urinary pregnanediol 3-glucuronide to confirm ovulation.

Authors:  R Ecochard; R Leiva; T Bouchard; H Boehringer; A Direito; A Mariani; R Fehring
Journal:  Steroids       Date:  2013-07-04       Impact factor: 2.668

8.  Monitoring of ovarian activity by measurement of urinary excretion rates of estrone glucuronide and pregnanediol glucuronide using the Ovarian Monitor, Part II: reliability of home testing.

Authors:  Leonard F Blackwell; Pilar Vigil; Barbara Gross; Catherine d'Arcangues; Delwyn G Cooke; James B Brown
Journal:  Hum Reprod       Date:  2011-11-29       Impact factor: 6.918

9.  Characterization of hormonal profiles during the luteal phase in regularly menstruating women.

Authors:  Rene Ecochard; Thomas Bouchard; Rene Leiva; Saman Abdulla; Olivier Dupuis; Olivia Duterque; Marie Garmier Billard; Hans Boehringer; Christophe Genolini
Journal:  Fertil Steril       Date:  2017-06-01       Impact factor: 7.329

Review 10.  The Use of Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide Excretion Rates to Navigate the Continuum of Ovarian Activity.

Authors:  Leonard F Blackwell; Delwyn G Cooke; Simon Brown
Journal:  Front Public Health       Date:  2018-05-31
View more
  1 in total

1.  Algorithms with Area under the Curve for Daily Urinary Estrone-3-Glucuronide and Pregnanediol-3-Glucuronide to Signal the Transition to the Luteal Phase.

Authors:  Stephen J Usala; María Elena Alliende; A Alexandre Trindade
Journal:  Medicina (Kaunas)       Date:  2022-01-13       Impact factor: 2.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.